Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
14.87
0.14 (0.95%)
At close: Sep 17, 2025, 3:15 PM
0.95% (1D)
| Bid | 14.86 |
| Market Cap | 12.38B |
| Revenue (ttm) | 334.26B |
| Net Income (ttm) | 56.8B |
| EPS (ttm) | 0.77 |
| PE Ratio (ttm) | 19.31 |
| Forward PE | 0.23 |
| Analyst | Strong Buy |
| Dividends | $0.19 |
| Ask | 14.87 |
| Volume | 1,342,973 |
| Avg. Volume (20D) | 1,220,233 |
| Open | 14.78 |
| Previous Close | 14.73 |
| Day's Range | 14.71 - 15.05 |
| 52-Week Range | 12.26 - 16.19 |
| Beta | 0.32 |
| Ex-Dividend Date | Jul 25, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RDY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsDr. Reddy's Laboratories Limited is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+5.29%
Dr. Reddy's Laboratories shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
+3.96%
Dr. Reddy's Laboratories shares are trading hgher on possible continued strength after reporting better-than-expected Q4 financial results on Friday.
1 month ago · seekingalpha.com
Dr. Reddy's Laboratories Limited (RDY) Q1 2026 Earnings Call TranscriptDr. Reddy's Laboratories Limited (NYSE:RDY ) Q1 2026 Earnings Conference Call July 23, 2025 10:00 AM ET Company Participants Erez Israeli - CEO & Member of the Management Council Mannam Venkatanarasim...
